Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Operating Expenses (2016 - 2021)

Historic Other Operating Expenses for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Q1 2021 value amounting to -$53000.0.

  • Avadel Pharmaceuticals' Other Operating Expenses fell 10188.01% to -$53000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$53000.0, marking a year-over-year decrease of 10010.91%. This contributed to the annual value of -$53000.0 for FY2021, which is 10011.58% down from last year.
  • Avadel Pharmaceuticals' Other Operating Expenses amounted to -$53000.0 in Q1 2021, which was down 10188.01% from $45.8 million recorded in Q2 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Other Operating Expenses registered a high of $72.8 million during Q4 2018, and its lowest value of -$53000.0 during Q1 2021.
  • In the last 5 years, Avadel Pharmaceuticals' Other Operating Expenses had a median value of $5.3 million in 2017 and averaged $13.9 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 125122.59% in 2018, then crashed by 10188.01% in 2021.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Other Operating Expenses stood at $5.4 million in 2017, then soared by 1251.23% to $72.8 million in 2018, then plummeted by 93.55% to $4.7 million in 2019, then surged by 874.65% to $45.8 million in 2020, then crashed by 100.12% to -$53000.0 in 2021.
  • Its Other Operating Expenses stands at -$53000.0 for Q1 2021, versus $45.8 million for Q2 2020 and $2.8 million for Q1 2020.